155 related articles for article (PubMed ID: 34664789)
1. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry.
Schleberger R; Metzner A; Kuck KH; Andresen D; Willems S; Hoffmann E; Deneke T; Eckardt L; Brachmann J; Hochadel M; Senges J; Rillig A
Pharmacol Res Perspect; 2021 Dec; 9(6):e00880. PubMed ID: 34664789
[TBL] [Abstract][Full Text] [Related]
2. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
[TBL] [Abstract][Full Text] [Related]
3. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
Mesquita J; Cavaco D; Ferreira AM; Costa FM; Carmo P; Morgado F; Mendes M; Adragão P
J Interv Card Electrophysiol; 2018 Jun; 52(1):39-45. PubMed ID: 29511973
[TBL] [Abstract][Full Text] [Related]
4. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
Kaitani K; Inoue K; Kobori A; Nakazawa Y; Ozawa T; Kurotobi T; Morishima I; Miura F; Watanabe T; Masuda M; Naito M; Fujimoto H; Nishida T; Furukawa Y; Shirayama T; Tanaka M; Okajima K; Yao T; Egami Y; Satomi K; Noda T; Miyamoto K; Haruna T; Kawaji T; Yoshizawa T; Toyota T; Yahata M; Nakai K; Sugiyama H; Higashi Y; Ito M; Horie M; Kusano KF; Shimizu W; Kamakura S; Morimoto T; Kimura T; Shizuta S;
Eur Heart J; 2016 Feb; 37(7):610-8. PubMed ID: 26417061
[TBL] [Abstract][Full Text] [Related]
6. Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort.
Lüker J; Sultan A; Sehner S; Hoffmann B; Servatius H; Willems S; Steven D
Heart Vessels; 2016 Oct; 31(10):1669-75. PubMed ID: 26546306
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
[TBL] [Abstract][Full Text] [Related]
8. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST).
Kuck KH; Lebedev DS; Mikhaylov EN; Romanov A; Gellér L; Kalējs O; Neumann T; Davtyan K; On YK; Popov S; Bongiorni MG; Schlüter M; Willems S; Ouyang F
Europace; 2021 Mar; 23(3):362-369. PubMed ID: 33330909
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drug therapy and all-cause mortality after catheter ablation of atrial fibrillation: A propensity-matched analysis.
Shantha G; Alyesh D; Ghanbari H; Yokokawa M; Saeed M; Cunnane R; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Chugh A; Morady F; Oral H
Heart Rhythm; 2019 Sep; 16(9):1368-1373. PubMed ID: 31201962
[TBL] [Abstract][Full Text] [Related]
11. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
Alhede C; Lauridsen TK; Johannessen A; Dixen U; Jensen JS; Raatikainen P; Hindricks G; Walfridsson H; Kongstad O; Pehrson S; Englund A; Hartikainen J; Hansen PS; Nielsen JC; Jons C
Int J Cardiol; 2017 Oct; 244():186-191. PubMed ID: 28506548
[TBL] [Abstract][Full Text] [Related]
13. Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
Malladi CL; Darden D; Aldaas O; Mylavarapu PS; Eskander M; Lupercio F; Han FT; Hoffmayer KS; Raissi F; Ho G; Krummen D; Feld GK; Hsu JC
PLoS One; 2021; 16(6):e0253266. PubMed ID: 34166392
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
Poole JE; Bahnson TD; Monahan KH; Johnson G; Rostami H; Silverstein AP; Al-Khalidi HR; Rosenberg Y; Mark DB; Lee KL; Packer DL;
J Am Coll Cardiol; 2020 Jun; 75(25):3105-3118. PubMed ID: 32586583
[TBL] [Abstract][Full Text] [Related]
15. Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences.
Kalman JM; Al-Kaisey AM; Parameswaran R; Hawson J; Anderson RD; Lim M; Chieng D; Joseph SA; McLellan A; Morton JB; Sparks PB; Lee G; Sanders P; Kistler PM
Eur Heart J; 2023 Jul; 44(27):2447-2454. PubMed ID: 37062010
[TBL] [Abstract][Full Text] [Related]
16. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
[TBL] [Abstract][Full Text] [Related]
17. Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.
Aldaas OM; Darden D; Mylavarapu PS; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Feld GK; Hsu JC
J Interv Card Electrophysiol; 2023 Aug; 66(5):1243-1252. PubMed ID: 36508065
[TBL] [Abstract][Full Text] [Related]
18. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
[TBL] [Abstract][Full Text] [Related]
19. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
[TBL] [Abstract][Full Text] [Related]
20. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
